Aarkstore - Atherosclerosis or Coronary Artery Disease (CAD) Therapeutics - Pipeline Assessment and Market Forecasts to 2018

1
Atherosclerosis or Coronary Artery Disease (CAD)
Therapeutics - Pipeline Assessment and Market
Forecasts to 2018

• Browse Complete Report
• http//www.aarkstore.com/pharmaceuticals-healthcar
  e/60320/atherosclerosis-or-coronary-artery-disease
  -cad-therapeutics-pipeline-assessment-and-market-f
  orecasts

Category  Pharmaceuticals Healthcare
2
Summary
the industry analysis specialist, has released
its new report, "Atherosclerosis or Coronary
Artery Disease (CAD) Therapeutics - Pipeline
Assessment and Market Forecasts to 2018". The
report is an essential source of information and
analysis on the global Atherosclerosis or
Coronary Artery Disease (CAD) Therapeutics
market. The report identifies the key trends
shaping and driving the global Atherosclerosis or
Coronary Artery Disease (CAD) Therapeutics
market. The report also provides insights on the
prevalent competitive landscape and the emerging
players expected to significantly alter the
market positioning of the current market leaders.
Most importantly, the report provides valuable
insights on the pipeline products within the
global Atherosclerosis or Coronary Artery Disease
(CAD) Therapeutics sector. This report is built
using data and information sourced from
proprietary databases, primary and secondary
research and in-house analysis by GlobalData's
team of industry experts.
http//www.aarkstore.com/pharmaceuticals-healthcar
e/60320/atherosclerosis-or-coronary-artery-disease
-cad-therapeutics-pipeline-assessment-and-market-f
orecasts
3
Scope
  The report provides information on the key
drivers and challenges of the Atherosclerosis or
Coronary Artery Disease (CAD) Therapeutics
market. Its scope includes - Annualized seven key
markets (US, France, Germany, Italy, Spain, UK
and Japan) Atherosclerosis or Coronary Artery
Disease (CAD) Therapeutics market revenues data
from 2005 to 2009, forecast for eight years to
2018. Pipeline analysis data providing a split
across the different phases, mechanisms of action
being developed and emerging trends by seven key
markets. Pipeline candidates fall under major
therapeutic classes. Analysis of the current and
future competition in the seven key countries
Atherosclerosis or Coronary Artery Disease (CAD)
Therapeutics market. Insightful review of the key
industry drivers, restraints and challenges. Each
trend is independently researched to provide a
qualitative analysis of its implications. Key
topics covered include strategic competitor
assessment, market characterization, unmet needs
and the implications for the Atherosclerosis or
Coronary Artery Disease (CAD) Therapeutics market.
4
Reasons To Buy
The report will enhance your decision making
capability. It will allow you to -   Develop and
design your in-licensing and out-licensing
strategies through a review of pipeline products
and technologies and by identifying the companies
with the most robust pipeline. Develop business
strategies by understanding the trends shaping
and driving the global Atherosclerosis or
Coronary Artery Disease (CAD) Therapeutics
market. Drive revenues by understanding the key
trends, innovative products and technologies,
market segments and companies likely to impact
the global Atherosclerosis or Coronary Artery
Disease (CAD) Therapeutics market in
future. Formulate effective sales and marketing
strategies by understanding the competitive
landscape and by analyzing the performance of
various competitors. Identify emerging players
with potentially strong product portfolios and
create effective counter-strategies to gain a
competitive advantage.
5
Table Of Content
2 Introduction 7  2.1 Overview 7 2.2 Types of
Atherosclerosis 7 2.3 Epidemiology 8 2.4 Etiology
9 2.4.1 Cells and Lipids 9 2.4.2 ECM
(Extracellular Matrix) 9 2.4.3 Endothelial Injury
as the Mechanism of Atherosclerosis 9 2.4.4 Role
of Low-Density Lipoprotein-Oxidative Stress
9 2.4.5 Risk Factors 10 2.5 Symptoms 11 2.6
Diagnosis 12 2.7 Pathophysiology 14 2.7.1
Pathological Pathway for Atherosclerosis 15 2.8
Treatment and Management Pattern 15 2.8.1 HMG-CoA
Reductase Inhibitors 15 2.8.2 ACE Inhibitors
15 2.8.3 Beta Blockers 16  
6
Special Discount Offer On Global Data Market
Research Reports at Aarkstore Buy 1 - 30
Discount Buy 2 - 40 discount Buy 3 to 5 - 50
discount Buy Site License - Get Global License
Access Offer valid till 31st December 2014 Browse
complete Report on http//www.aarkstore.com/disco
unt.php
7
Discount Reports

• Methicillin-resistant Staphylococcus aureus
  (MRSA) Therapeutics - Pipeline Assessment and
  Market Forecasts to 2019
• Hepatitis A Preventive Vaccines - Pipeline
  Assessment and Market Forecasts to 2019
• Toxoplasmosis Therapeutics - Pipeline Assessment
  and Market Forecasts to 2019
• Skin and Skin Structure Infections (SSSI)
  Therapeutics - Pipeline Assessment and Market
  Forecasts to 2019
• Gauchers Disease Therapeutics - Pipeline
  Assessment and Market Forecasts to 2018
• Sarcoidosis Therapeutics - Pipeline Assessment
  and Market Forecasts to 2019
• Pompe Disease (GAA Deficiency) Therapeutics -
  Pipeline Assessment and Market Forecasts to 2019
• Cushings Syndrome Therapeutics - Pipeline
  Assessment and Market Forecasts to 2019
• Amyloidosis Therapeutics - Pipeline Assessment
  and Market Forecasts to 2019
• Addisons Disease (Primary or Chronic Adrenal
  Insufficiency) Therapeutics - Pipeline Assessment
  and Market Forecasts to 2019

8
Atherosclerosis or Coronary Artery Disease (CAD)
Therapeutics - Pipeline Assessment and Market
Forecasts to 2018 Published Jan 2012
 111Pages The report is an essential source of
information and analysis on the global
Atherosclerosis or Coronary Artery Disease (CAD)
Therapeutics market. The report identifies the
key trends shaping and driving the global
Atherosclerosis or Coronary Artery Disease (CAD)
Therapeutics market.   
9
Contact Us
Office Aarkstore Enterprise Office No. - 809, 8th Floor, B-Wing, Mahaavir Icon, Plot No.- 89 90, Sector-15, CBD-Belapur, Navi Mumbai 400614, , Maharashtra, India, 24/7 Online Support 91 814 985 2585 Partners contact 91 808 085 2585 Cell and Enquiry - 9987295242 Landline No 022-27564963
You Can Visit http//www.aarkstore.com OR Mail us at contact_at_aarkstore.com Blog http//www.aarkstore.com/blog/ Conference http//conference.aarkstore.com/ News http//www.aarkstore.com/news.php